KNX-100

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameKNX-100
Drug Alias NameSOC1KNX-100
ClassificationSmall molecules
Mechanisms of ActionOxytocin receptor modulators
TargetsOxytocin receptor
Therapy Area/IndicationsOpioid-Related DisordersSubstance-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of Sydney
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsOpioid-Related DisordersSubstance-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A